SANN — Santhera Pharmaceuticals Holding AG Share News
0.000.00%
Last trade - 00:00- CH₣220.90m
- CH₣220.41m
- CH₣77.19m
Swiss stocks - Factors to watch on March 11
Swiss stocks - Factors to watch on February 18
Swiss stocks - Factors to watch on January 4
Swiss stocks - Factors to watch on Oct 18
Europe Research Roundup: Antofagasta, Salvatore Ferragamo SpA, Vestas
Brief: Santhera Pharmaceuticals Announces Positive Topline Results From Its Long-Term Phase 4 Leros Study With Raxone
Europe Research Roundup: Elis SA, Experian, Nokia Oyj
Brief: Santhera And Reveragen Announce Positive Topline Results With Vamorolone In Vision-DMD Study
Brief: Santhera Completes Capital Increase For Financing Arrangements
Europe Research Roundup: Ashtead Group, Finecobank, United Internet
Brief: Santhera Announces Settlement of Convertible Bond Exchange Offer
Swiss stocks - Factors to watch on May 3
Brief: Santhera Completes Capital Increases
Swiss stocks - Factors to watch on April 29
Brief: Santhera FY Net Loss Widens To CHF 67.7 Million
Brief: Santhera And Reveragen Announce New 2.5-Year Treatment Data With Vamorolone
Swiss stocks - Factors to watch on April 28
Brief: Santhera Reports Interim Results On Convertible Bond Exchange Offer
Brief: Santhera Starts Convertible Bond Exchange Offer